Fabricator: Dragon Pharma, Europe
Unit: x1 10 ml
Strength: 270 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragon Pharma Sustanon 270 delivers 270 mg of combined testosterone esters per milliliter in a sophisticated multi-ester oil solution. This formulation unites five distinct ester variants into a single injection for comprehensive hormonal coverage.
The blend pairs rapid-acting Acetate and Propionate with medium and long-acting Phenylpropionate, Isocaproate, and Decanoate. Users experience immediate anabolic activation within 24–48 hours alongside stable plasma levels that persist for weeks.
This parenteral suspension contains Testosterone Acetate (20 mg), Testosterone Propionate (30 mg), Testosterone Phenylpropionate (60 mg), Testosterone Isocaproate (60 mg), and Testosterone Decanoate (100 mg) per milliliter.
The staggered ester release kinetics create a balanced hormonal profile. Short esters provide an early anabolic surge while longer variants maintain steady receptor saturation without the pronounced peaks and troughs of single-ester protocols.
The result is consistent energy, predictable mood stability, and uniform muscular response across the entire cycle duration. Water retention tends to distribute more evenly compared to isolated long-ester administrations.
Dragon Pharma subjects every batch to independent analytical verification. Recent testing confirmed 271.26 mg/mL actual potency, demonstrating exceptional manufacturing precision and batch consistency.
Each milliliter contains 20 mg Testosterone Acetate, 30 mg Testosterone Propionate, 60 mg Testosterone Phenylpropionate, 60 mg Testosterone Isocaproate, and 100 mg Testosterone Decanoate.
The formulation utilizes pharmaceutical-grade carrier oils, benzyl alcohol as an antimicrobial preservative, and co-solvents to ensure stable multi-ester suspension and optimal pharmacokinetics.
All raw materials undergo independent verification for identity, potency, and sterility prior to compounding.
Administer via deep intramuscular injection into large muscle groups. Rotate between the gluteal muscles, vastus lateralis, and deltoids to prevent localized tissue fibrosis.
Warm the vial gently to body temperature before drawing to reduce viscosity. Aspirate prior to plunging to confirm extravascular placement.
Maintain strict aseptic technique. Cleanse the rubber septum with isopropyl alcohol before each access. Utilize sterile needles for every administration and never share injection equipment.
Store unopened vials in a temperature-stable environment between 15–30°C (59–86°F), shielded from direct light. Do not freeze.
Beginners typically administer 250–500 mg weekly, split into two injections. This equates to approximately 1 mL twice weekly for a 540 mg total.
Intermediate users may increase to 500–750 mg weekly, divided into two or three administrations to maintain hormonal stability.
Advanced protocols can reach 750–1000 mg or more weekly. At these doses, every-other-day or three-times-weekly injection schedules minimize estrogenic fluctuations and post-injection discomfort.
Due to the higher concentration, warming the oil and meticulous site rotation are essential for injection comfort.
The substantial testosterone load drives significant aromatization. Water retention, elevated blood pressure, and gynecomastia can develop without proactive estrogen management.
Aromatase inhibitor therapy is essential from the outset. The short esters cause early estrogenic activity that requires immediate ancillary support.
Androgenic manifestations including acne, increased sebum production, and accelerated scalp hair thinning in genetically predisposed individuals are common at elevated doses.
Exogenous testosterone completely suppresses hypothalamic-pituitary-gonadal axis function. A comprehensive Post-Cycle Therapy protocol is mandatory.
Wait approximately 3 weeks after the final injection before initiating PCT. The long Decanoate ester requires this extended clearance period.
Lipid profiles may shift unfavorably, with HDL suppression and LDL elevation. Regular cardiovascular exercise and heart-healthy dietary practices are essential.
This product is intended exclusively for research purposes and use by qualified adults under appropriate supervision. It is not suitable for minors, women, or individuals with pre-existing hepatic, cardiovascular, or prostate conditions.
Regular blood work monitoring total testosterone, estradiol, liver enzymes, and lipids is essential throughout the cycle. Adjust ancillary dosing based on objective laboratory values.
Maintain a heart-healthy diet rich in omega-3 fatty acids and low in saturated fats. Regular cardiovascular exercise supports vascular health and lipid management.
Discontinue immediately and seek medical evaluation if severe chest pain, shortness of breath, jaundice, or profound mood disturbances develop.
Please log in to write Sustanon 270 review.
Single-ester compounds deliver either rapid onset with short duration or slow buildup with extended release. Sustanon 270 combines both profiles.
The five-ester matrix provides immediate anabolic activity alongside sustained hormonal coverage from a single injection.
Twice weekly is the minimum effective frequency due to the Acetate and Propionate components. Higher doses benefit from every-other-day administration.
This prevents hormonal fluctuations that can amplify estrogenic and androgenic side effects.
Wait 3 weeks after the final injection. The Testosterone Decanoate ester has an extended elimination half-life that requires this clearance window.
Starting PCT too early is ineffective because exogenous hormones remain in circulation.
It is highly versatile for both objectives. Higher doses with caloric surpluses drive mass accretion. Moderate doses with deficits preserve lean tissue during fat loss.
The key is adjusting total dosage, ancillary support, and nutritional strategy to match the goal.
Minor manufacturing variances are normal and expected. All tested batches fall within acceptable pharmaceutical tolerance ranges.
Some batches show slight overfill to guarantee minimum labeled potency, while others align closely with the 270 mg/mL claim.